1 Introduction to Research & Analysis Reports
1.1 Anti-VEGF Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-VEGF Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-VEGF Medicine Overall Market Size
2.1 Global Anti-VEGF Medicine Market Size: 2021 VS 2028
2.2 Global Anti-VEGF Medicine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Anti-VEGF Medicine Sales: 2017-2028
3 Company Landscape
3.1 Top Anti-VEGF Medicine Players in Global Market
3.2 Top Global Anti-VEGF Medicine Companies Ranked by Revenue
3.3 Global Anti-VEGF Medicine Revenue by Companies
3.4 Global Anti-VEGF Medicine Sales by Companies
3.5 Global Anti-VEGF Medicine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Anti-VEGF Medicine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Anti-VEGF Medicine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-VEGF Medicine Players in Global Market
3.8.1 List of Global Tier 1 Anti-VEGF Medicine Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-VEGF Medicine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Anti-VEGF Medicine Market Size Markets, 2021 & 2028
4.1.2 Single Target (Ranibizumab, etc.)
4.1.3 Multiple Targets (Aflibercept, Conbercept, etc.)
4.2 By Type – Global Anti-VEGF Medicine Revenue & Forecasts
4.2.1 By Type – Global Anti-VEGF Medicine Revenue, 2017-2022
4.2.2 By Type – Global Anti-VEGF Medicine Revenue, 2023-2028
4.2.3 By Type – Global Anti-VEGF Medicine Revenue Market Share, 2017-2028
4.3 By Type – Global Anti-VEGF Medicine Sales & Forecasts
4.3.1 By Type – Global Anti-VEGF Medicine Sales, 2017-2022
4.3.2 By Type – Global Anti-VEGF Medicine Sales, 2023-2028
4.3.3 By Type – Global Anti-VEGF Medicine Sales Market Share, 2017-2028
4.4 By Type – Global Anti-VEGF Medicine Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application – Global Anti-VEGF Medicine Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Eye Clinic
5.1.4 Other
5.2 By Application – Global Anti-VEGF Medicine Revenue & Forecasts
5.2.1 By Application – Global Anti-VEGF Medicine Revenue, 2017-2022
5.2.2 By Application – Global Anti-VEGF Medicine Revenue, 2023-2028
5.2.3 By Application – Global Anti-VEGF Medicine Revenue Market Share, 2017-2028
5.3 By Application – Global Anti-VEGF Medicine Sales & Forecasts
5.3.1 By Application – Global Anti-VEGF Medicine Sales, 2017-2022
5.3.2 By Application – Global Anti-VEGF Medicine Sales, 2023-2028
5.3.3 By Application – Global Anti-VEGF Medicine Sales Market Share, 2017-2028
5.4 By Application – Global Anti-VEGF Medicine Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region – Global Anti-VEGF Medicine Market Size, 2021 & 2028
6.2 By Region – Global Anti-VEGF Medicine Revenue & Forecasts
6.2.1 By Region – Global Anti-VEGF Medicine Revenue, 2017-2022
6.2.2 By Region – Global Anti-VEGF Medicine Revenue, 2023-2028
6.2.3 By Region – Global Anti-VEGF Medicine Revenue Market Share, 2017-2028
6.3 By Region – Global Anti-VEGF Medicine Sales & Forecasts
6.3.1 By Region – Global Anti-VEGF Medicine Sales, 2017-2022
6.3.2 By Region – Global Anti-VEGF Medicine Sales, 2023-2028
6.3.3 By Region – Global Anti-VEGF Medicine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country – North America Anti-VEGF Medicine Revenue, 2017-2028
6.4.2 By Country – North America Anti-VEGF Medicine Sales, 2017-2028
6.4.3 US Anti-VEGF Medicine Market Size, 2017-2028
6.4.4 Canada Anti-VEGF Medicine Market Size, 2017-2028
6.4.5 Mexico Anti-VEGF Medicine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country – Europe Anti-VEGF Medicine Revenue, 2017-2028
6.5.2 By Country – Europe Anti-VEGF Medicine Sales, 2017-2028
6.5.3 Germany Anti-VEGF Medicine Market Size, 2017-2028
6.5.4 France Anti-VEGF Medicine Market Size, 2017-2028
6.5.5 U.K. Anti-VEGF Medicine Market Size, 2017-2028
6.5.6 Italy Anti-VEGF Medicine Market Size, 2017-2028
6.5.7 Russia Anti-VEGF Medicine Market Size, 2017-2028
6.5.8 Nordic Countries Anti-VEGF Medicine Market Size, 2017-2028
6.5.9 Benelux Anti-VEGF Medicine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region – Asia Anti-VEGF Medicine Revenue, 2017-2028
6.6.2 By Region – Asia Anti-VEGF Medicine Sales, 2017-2028
6.6.3 China Anti-VEGF Medicine Market Size, 2017-2028
6.6.4 Japan Anti-VEGF Medicine Market Size, 2017-2028
6.6.5 South Korea Anti-VEGF Medicine Market Size, 2017-2028
6.6.6 Southeast Asia Anti-VEGF Medicine Market Size, 2017-2028
6.6.7 India Anti-VEGF Medicine Market Size, 2017-2028
6.7 South America
6.7.1 By Country – South America Anti-VEGF Medicine Revenue, 2017-2028
6.7.2 By Country – South America Anti-VEGF Medicine Sales, 2017-2028
6.7.3 Brazil Anti-VEGF Medicine Market Size, 2017-2028
6.7.4 Argentina Anti-VEGF Medicine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Anti-VEGF Medicine Revenue, 2017-2028
6.8.2 By Country – Middle East & Africa Anti-VEGF Medicine Sales, 2017-2028
6.8.3 Turkey Anti-VEGF Medicine Market Size, 2017-2028
6.8.4 Israel Anti-VEGF Medicine Market Size, 2017-2028
6.8.5 Saudi Arabia Anti-VEGF Medicine Market Size, 2017-2028
6.8.6 UAE Anti-VEGF Medicine Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Faricimab
7.1.1 Faricimab Corporate Summary
7.1.2 Faricimab Business Overview
7.1.3 Faricimab Anti-VEGF Medicine Major Product Offerings
7.1.4 Faricimab Anti-VEGF Medicine Sales and Revenue in Global (2017-2022)
7.1.5 Faricimab Key News
7.2 Bayer (Regeneron)
7.2.1 Bayer (Regeneron) Corporate Summary
7.2.2 Bayer (Regeneron) Business Overview
7.2.3 Bayer (Regeneron) Anti-VEGF Medicine Major Product Offerings
7.2.4 Bayer (Regeneron) Anti-VEGF Medicine Sales and Revenue in Global (2017-2022)
7.2.5 Bayer (Regeneron) Key News
7.3 Brolucizumab
7.3.1 Brolucizumab Corporate Summary
7.3.2 Brolucizumab Business Overview
7.3.3 Brolucizumab Anti-VEGF Medicine Major Product Offerings
7.3.4 Brolucizumab Anti-VEGF Medicine Sales and Revenue in Global (2017-2022)
7.3.5 Brolucizumab Key News
7.4 Kanghong Pharmaceutical
7.4.1 Kanghong Pharmaceutical Corporate Summary
7.4.2 Kanghong Pharmaceutical Business Overview
7.4.3 Kanghong Pharmaceutical Anti-VEGF Medicine Major Product Offerings
7.4.4 Kanghong Pharmaceutical Anti-VEGF Medicine Sales and Revenue in Global (2017-2022)
7.4.5 Kanghong Pharmaceutical Key News
7.5 Santen
7.5.1 Santen Corporate Summary
7.5.2 Santen Business Overview
7.5.3 Santen Anti-VEGF Medicine Major Product Offerings
7.5.4 Santen Anti-VEGF Medicine Sales and Revenue in Global (2017-2022)
7.5.5 Santen Key News
8 Global Anti-VEGF Medicine Production Capacity, Analysis
8.1 Global Anti-VEGF Medicine Production Capacity, 2017-2028
8.2 Anti-VEGF Medicine Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-VEGF Medicine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-VEGF Medicine Supply Chain Analysis
10.1 Anti-VEGF Medicine Industry Value Chain
10.2 Anti-VEGF Medicine Upstream Market
10.3 Anti-VEGF Medicine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-VEGF Medicine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Table 1. Key Players of Anti-VEGF Medicine in Global Market
Table 2. Top Anti-VEGF Medicine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Anti-VEGF Medicine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Anti-VEGF Medicine Revenue Share by Companies, 2017-2022
Table 5. Global Anti-VEGF Medicine Sales by Companies, (K Units), 2017-2022
Table 6. Global Anti-VEGF Medicine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Anti-VEGF Medicine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Anti-VEGF Medicine Product Type
Table 9. List of Global Tier 1 Anti-VEGF Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-VEGF Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Anti-VEGF Medicine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Anti-VEGF Medicine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Anti-VEGF Medicine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Anti-VEGF Medicine Sales (K Units), 2017-2022
Table 15. By Type - Global Anti-VEGF Medicine Sales (K Units), 2023-2028
Table 16. By Application – Global Anti-VEGF Medicine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Anti-VEGF Medicine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Anti-VEGF Medicine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Anti-VEGF Medicine Sales (K Units), 2017-2022
Table 20. By Application - Global Anti-VEGF Medicine Sales (K Units), 2023-2028
Table 21. By Region – Global Anti-VEGF Medicine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Anti-VEGF Medicine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Anti-VEGF Medicine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Anti-VEGF Medicine Sales (K Units), 2017-2022
Table 25. By Region - Global Anti-VEGF Medicine Sales (K Units), 2023-2028
Table 26. By Country - North America Anti-VEGF Medicine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Anti-VEGF Medicine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Anti-VEGF Medicine Sales, (K Units), 2017-2022
Table 29. By Country - North America Anti-VEGF Medicine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Anti-VEGF Medicine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Anti-VEGF Medicine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Anti-VEGF Medicine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Anti-VEGF Medicine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Anti-VEGF Medicine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Anti-VEGF Medicine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Anti-VEGF Medicine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Anti-VEGF Medicine Sales, (K Units), 2023-2028
Table 38. By Country - South America Anti-VEGF Medicine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Anti-VEGF Medicine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Anti-VEGF Medicine Sales, (K Units), 2017-2022
Table 41. By Country - South America Anti-VEGF Medicine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Anti-VEGF Medicine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Anti-VEGF Medicine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Anti-VEGF Medicine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Anti-VEGF Medicine Sales, (K Units), 2023-2028
Table 46. Faricimab Corporate Summary
Table 47. Faricimab Anti-VEGF Medicine Product Offerings
Table 48. Faricimab Anti-VEGF Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Bayer (Regeneron) Corporate Summary
Table 50. Bayer (Regeneron) Anti-VEGF Medicine Product Offerings
Table 51. Bayer (Regeneron) Anti-VEGF Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Brolucizumab Corporate Summary
Table 53. Brolucizumab Anti-VEGF Medicine Product Offerings
Table 54. Brolucizumab Anti-VEGF Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Kanghong Pharmaceutical Corporate Summary
Table 56. Kanghong Pharmaceutical Anti-VEGF Medicine Product Offerings
Table 57. Kanghong Pharmaceutical Anti-VEGF Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Santen Corporate Summary
Table 59. Santen Anti-VEGF Medicine Product Offerings
Table 60. Santen Anti-VEGF Medicine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Anti-VEGF Medicine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 62. Global Anti-VEGF Medicine Capacity Market Share of Key Manufacturers, 2020-2022
Table 63. Global Anti-VEGF Medicine Production by Region, 2017-2022 (K Units)
Table 64. Global Anti-VEGF Medicine Production by Region, 2023-2028 (K Units)
Table 65. Anti-VEGF Medicine Market Opportunities & Trends in Global Market
Table 66. Anti-VEGF Medicine Market Drivers in Global Market
Table 67. Anti-VEGF Medicine Market Restraints in Global Market
Table 68. Anti-VEGF Medicine Raw Materials
Table 69. Anti-VEGF Medicine Raw Materials Suppliers in Global Market
Table 70. Typical Anti-VEGF Medicine Downstream
Table 71. Anti-VEGF Medicine Downstream Clients in Global Market
Table 72. Anti-VEGF Medicine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-VEGF Medicine Segment by Type
Figure 2. Anti-VEGF Medicine Segment by Application
Figure 3. Global Anti-VEGF Medicine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Anti-VEGF Medicine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anti-VEGF Medicine Revenue, 2017-2028 (US$, Mn)
Figure 7. Anti-VEGF Medicine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-VEGF Medicine Revenue in 2021
Figure 9. By Type - Global Anti-VEGF Medicine Sales Market Share, 2017-2028
Figure 10. By Type - Global Anti-VEGF Medicine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Anti-VEGF Medicine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Anti-VEGF Medicine Sales Market Share, 2017-2028
Figure 13. By Application - Global Anti-VEGF Medicine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Anti-VEGF Medicine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Anti-VEGF Medicine Sales Market Share, 2017-2028
Figure 16. By Region - Global Anti-VEGF Medicine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Anti-VEGF Medicine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Anti-VEGF Medicine Sales Market Share, 2017-2028
Figure 19. US Anti-VEGF Medicine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Anti-VEGF Medicine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Anti-VEGF Medicine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Anti-VEGF Medicine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Anti-VEGF Medicine Sales Market Share, 2017-2028
Figure 24. Germany Anti-VEGF Medicine Revenue, (US$, Mn), 2017-2028
Figure 25. France Anti-VEGF Medicine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Anti-VEGF Medicine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Anti-VEGF Medicine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Anti-VEGF Medicine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Anti-VEGF Medicine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Anti-VEGF Medicine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Anti-VEGF Medicine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Anti-VEGF Medicine Sales Market Share, 2017-2028
Figure 33. China Anti-VEGF Medicine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Anti-VEGF Medicine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Anti-VEGF Medicine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Anti-VEGF Medicine Revenue, (US$, Mn), 2017-2028
Figure 37. India Anti-VEGF Medicine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Anti-VEGF Medicine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Anti-VEGF Medicine Sales Market Share, 2017-2028
Figure 40. Brazil Anti-VEGF Medicine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Anti-VEGF Medicine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Anti-VEGF Medicine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Anti-VEGF Medicine Sales Market Share, 2017-2028
Figure 44. Turkey Anti-VEGF Medicine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Anti-VEGF Medicine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Anti-VEGF Medicine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Anti-VEGF Medicine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Anti-VEGF Medicine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Anti-VEGF Medicine by Region, 2021 VS 2028
Figure 50. Anti-VEGF Medicine Industry Value Chain
Figure 51. Marketing Channels
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer